SIGMA1 Gene

SIGMA1 Gene

Introduction

SIGMA1 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SIGMA1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SIGMA1 (SIGMAR1)</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Sigma Non-Opioid Intracellular Receptor 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9p13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10280</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000147955</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q99720</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>601978</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">E102Q</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">L95del</td>
<td>Deletion</td>
</tr>
<tr>
<td class="label">A156T</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">IP3R</td>
<td>Calcium regulation</td>
</tr>
<tr>
<td class="label">BiP</td>
<td>ER chaperone interaction</td>
</tr>
<tr>
<td class="label">VDAC</td>
<td>Mitochondrial coupling</td>
</tr>
<tr>
<td class="label">BDNF</td>
<td>Signaling modulation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The SIGMA1 gene (Sigma Non-Opioid Intracellular Receptor 1, also known as SIGMAR1) encodes a unique chaperone protein that operates as a ligand-operated molecular chaperone in the endoplasmic reticulum. The Sigma-1 receptor is a distinct pharmacological entity that binds various psychoactive compounds and plays critical roles in cellular homeostasis, calcium signaling, and neuroprotection. This receptor has emerged as an important therapeutic target for neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. [@sigma2023]

Gene Overview

Protein Product

The Sigma-1 receptor is a small 223-amino acid integral membrane protein primarily located in the endoplasmic reticulum (ER). It functions as a unique ligand-operated chaperone that can modulate various cellular processes. Unlike classical G-protein coupled receptors, Sigma-1 operates through chaperone-based mechanisms. [@structure2022]

Structure

• Size: 223 amino acids (~25 kDa)
• Topology: Single transmembrane domain
• Localization: Endoplasmic reticulum, plasma membrane, mitochondria-associated membranes
• Oligomerization: Forms homodimers and higher-order complexes

Function

The Sigma-1 receptor exhibits diverse biological functions:

Signaling Mechanisms

• IP3R Modulation: Controls calcium release from ER
• BDNF Signaling: Enhances neurotrophic factor signaling
• ER Stress Response: Modulates unfolded protein response
• Autophagy Regulation: Controls autophagy flux

Disease Associations

Alzheimer's Disease

Sigma-1 receptor has significant relevance to AD:

• Expression is altered in AD brains
• Agonists protect against amyloid-beta toxicity
• Modulates tau phosphorylation and aggregation
• Enhances BDNF signaling [@sigma2023a]

Parkinson's Disease

The receptor shows therapeutic potential in PD:

• Protects dopaminergic neurons
• Modulates mitochondrial function
• May reduce alpha-synuclein aggregation
• Clinical trials with Sigma-1 agonists underway [@therapeutic2022]

Amyotrophic Lateral sclerosis (ALS)

• Sigma-1 mutations cause juvenile ALS
• Receptor dysfunction leads to motor neuron degeneration
• Agonists show protective effects in models
• Gene therapy approaches being explored [@sigmar2023]

Other Conditions

• Huntington's Disease: Neuroprotective effects
• Depression: Antidepressant-like effects of agonists
• Retinopathy: Protective effects in retinal degeneration
• Cancer: Some tumors express Sigma-1

Mutations

Pathogenic Variants

Polymorphisms

• Various SNPs associated with disease risk
• Linkage with psychiatric conditions investigated
• Pharmacogenomic considerations for drug response [@pharmacogenomics2022]

Therapeutic Relevance

Therapeutic Targets

Drug Development

• Donepezil: Sigma-1 agonist in use for AD
• SA-4503: Selective Sigma-1 agonist
• Pentoxyifylline: Sigma-1 modulator
• PRE-084: Selective agonist [@sigma2024]

Clinical Applications

• Neurodegenerative disease treatment
• Cognitive enhancement
• Anti-stress effects
• Analgesia

Interactions

Protein Partners

Ligand Interactions

• Endogenous Ligands: Neurosteroids (pregnenolone, DHEA)
• Synthetic Agonists: Various pharmaceutical compounds
• Antagonists:rimcazole, haloperidol

Signaling Pathways

• Calcium signaling
• ER stress response
• [Autophagy](/mechanisms/autophagy)
• Mitochondrial function [@sigma2023b]

Research Directions

Current research focuses on:

• Developing brain-penetrant Sigma-1 agonists
• Understanding receptor structure
• Clinical trials in neurodegenerative diseases
• Biomarker development

References

Pathway Diagram

The following diagram shows the key molecular relationships involving SIGMA1 Gene discovered through SciDEX knowledge graph analysis: